Posts With Tag EU Market Abuse Regulation

Explore AstraZeneca's August 2025 Form 6-K detailing an insider share sale by CFO Aradhana Sarin. Key transaction insights and compliance with EU regulations included.

AstraZeneca's Form 6-K reveals CEO Pascal Soriot's acquisition of 8,970 shares post-vesting. Key insights on performance, compliance, and tax obligations included.